Loading…
This event has ended. Create your own event on Sched.
Back To Schedule
Friday, March 2 • 7:00am - 8:00am
PO076: Prospective Multicenter Trial Of A Compounded Fixed Combination Of Latanoprost 0.005%, Dorzolamide Hydrochloride 2%, Timolol Maleate 0.5%, Brimonidine Tartrate 0.2% For Glaucoma

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Speakers

Friday March 2, 2018 7:00am - 8:00am EST
Astor Ballroom New York Marriott Marquis, New York, NY